关注
Kirk Anderson
Kirk Anderson
Reconstructive Urology, Sutter Medical Center, Sacramento, CA
在 puc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Reduced fluoroscopy protocol for percutaneous nephrostolithotomy: feasibility, outcomes and effects on fluoroscopy time
B Blair, G Huang, D Arnold, R Li, A Schlaifer, K Anderson, S Engebretsen, ...
The Journal of urology 190 (6), 2112-2116, 2013
702013
Laparoscopic donor nephrectomy: effect of perirenal fat upon donor operative time
KM Anderson, TU Lindler, GR Lamberton, PW Baron, OK Ojogho, ...
Journal of endourology 22 (10), 2269-2274, 2008
692008
Urinary incontinence and pelvic organ prolapse
KM Anderson, K Davis, BJ Flynn
Medical Clinics 99 (2), 405-416, 2015
412015
Fluoro-less ureteral stent placement following uncomplicated ureteroscopic stone removal: a feasibility study
W Brisbane, D Smith, A Schlaifer, K Anderson, DD Baldwin
Urology 80 (4), 766-770, 2012
292012
Primary non-transecting bulbar urethroplasty long-term success rates are similar to transecting urethroplasty
KM Anderson, SA Blakely, CI O’Donnell, D Nikolavsky, BJ Flynn
International urology and nephrology 49, 83-88, 2017
252017
Management of the devastated posterior urethra and bladder neck: refractory incontinence and stenosis
KM Anderson, TT Higuchi, BJ Flynn
Translational Andrology and Urology 4 (1), 60, 2015
202015
Ureteral calculi detection using low dose computerized tomography protocols is compromised in overweight and underweight patients
JP Heldt, JC Smith, KM Anderson, GD Richards, G Agarwal, DL Smith, ...
The Journal of urology 188 (1), 124-129, 2012
162012
Prostate specific antigen levels and prostate cancer detection rates in patients with end stage renal disease
CJ Chen, JP Heldt, KM Anderson, HC Ruckle, G Agarwal, DL Smith, ...
The Journal of urology 187 (6), 2061-2067, 2012
132012
Comparison of cellular gene expression in Ebola-Zaire and Ebola-Reston virus-infected primary human monocytes
C Xiang, H Young, H Alterson, D Reynolds, M Bittner, Y Chen, G Gooden, ...
Nature Genetics 23 (3), 82-82, 1999
101999
Creation of a continent urinary channel in adults with neurogenic bladder: Long-term results with the Monti and Casale (Spiral Monti) procedures
D Hadley, K Anderson, CR Knopick, K Shah, BJ Flynn
Urology 83 (5), 1176-1180, 2014
92014
In automated fluoroscopy settings, does shielding affect radiation exposure to surrounding unshielded tissues?
KK Nguyen, AE Schlaifer, DL Smith, KM Anderson, DC Arnold, JP Heldt, ...
Journal of endourology 26 (11), 1489-1493, 2012
92012
ASP Conf. Ser. Vol. 523, Astronomical Data Analysis Software and Systems XXVII
K Labrie, K Anderson, R Cárdenes, C Simpson, JEH Turner, PJ Teuben, ...
Astron. Soc. Pac, San Francisco, 2019
62019
Prospective study of the Transurethral Suprapubic endo-Cystostomy (T-SPEC®): an ‘inside-out’ approach to suprapubic catheter insertion
BJ Flynn, RJ Larke, PB Knoll, KM Anderson, VJ Siomos, AP Windsperger
International Urology and Nephrology 47, 257-262, 2015
62015
A prospective analysis of robotic tip cover accessory failure
SR Engebretsen, GO Huang, CL Wallner, KM Anderson, AE Schlaifer, ...
Journal of Endourology 27 (7), 914-917, 2013
62013
Robotic-assisted surgery and the evolution of the radical prostatectomy.
KM Anderson, HC Ruckle, DD Baldwin
Minerva Urologica e Nefrologica= The Italian Journal of Urology and …, 2012
62012
New England journal of medicine
A Palumbo, K Anderson
NEJM 364 (11)), 1046-1060, 2011
62011
Laparoscopic and robotic pyeloplasty collaborative group: Analysis of factors influencing success in 800 patients
SM Lucas, CP Sundaram, RJ Leveillee, VG Bird, M Aziz, SE Pautler, ...
JOURNAL OF ENDOUROLOGY 24, A31-A32, 2010
62010
Peripheral blood progenitor cells (PBPC) s added to bone marrow (BM) for hemopoietic rescue following high dose chemotherapy for solid tumors reduces morbidity and length of …
R Mazanet, A Elias, M Hunt, L Ayash, K Anderson, K Wheeler, G Schwartz, ...
Rot Am Sot Ch Oncol 10, 1991
61991
the Solid Tumor Autologous Bone Marrow Team. High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute …
K Antman, JP Eder, A Elias, T Shea, WP Peter, J Anderson, S Schryber, ...
Cancer Treat Rep 71, 119-125, 1987
61987
Treatment of 58 patients on a phase I and II protocol using a high dose combination alkylating agent preparative regimen with autologous bone marrow support
K Antman, WP Peters, JP Eder, S Schryber, J Anderson, WD Henner, ...
Accomplishments in Cancer Research Philladelphia PA, JB Lippincott, 152-165, 1985
61985
系统目前无法执行此操作,请稍后再试。
文章 1–20